The only published study that directly manipulated OPN receptors in human breast cancer utilized a CD44 neutralizing antibody in MDA-MB-231 and they observed that antibody mediated suppression of CD44 signaling inhibited migration [46]. The gene discussed is CD44; the disease is breast carcinoma.